-
1
-
-
0043181917
-
Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures
-
Ben-Menachem E, Henriksen O, Dam M, Mikkelsen M, Schmidt D, Reid S, Reife R, Kramer L, Pledger G, Karim R. Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures. Epilepsia 1996;37:539-43.
-
(1996)
Epilepsia
, vol.37
, pp. 539-543
-
-
Ben-Menachem, E.1
Henriksen, O.2
Dam, M.3
Mikkelsen, M.4
Schmidt, D.5
Reid, S.6
Reife, R.7
Kramer, L.8
Pledger, G.9
Karim, R.10
-
2
-
-
0000337340
-
The novel anticonvulsant topiramate enhances GABA-mediated chloride flux
-
Brown SD, Wolf H, Swinyard EA, Twyman RE, White HS. The novel anticonvulsant topiramate enhances GABA-mediated chloride flux. Epilepsia 1993;34(Suppl 2):122.
-
(1993)
Epilepsia
, vol.34
, Issue.2 SUPPL.
, pp. 122
-
-
Brown, S.D.1
Wolf, H.2
Swinyard, E.A.3
Twyman, R.E.4
White, H.S.5
-
3
-
-
0000337336
-
Selective effects of topiramate on sustained repetitive firing and spontaneous bursting in cultured hippocampal neurons
-
Coulter DA, Sombati S, DeLorenzo RJ. Selective effects of topiramate on sustained repetitive firing and spontaneous bursting in cultured hippocampal neurons. Epilepsia 1993;34(Suppl 2):123.
-
(1993)
Epilepsia
, vol.34
, Issue.2 SUPPL.
, pp. 123
-
-
Coulter, D.A.1
Sombati, S.2
DeLorenzo, R.J.3
-
4
-
-
70449177837
-
A note on a simple apparatus for detecting neurological deficit in rats and mice
-
Dunham MS, Miya TA. A note on a simple apparatus for detecting neurological deficit in rats and mice. J Am Pharm Assoc Sci Ed 1957;46:208-9.
-
(1957)
J Am Pharm Assoc Sci Ed
, vol.46
, pp. 208-209
-
-
Dunham, M.S.1
Miya, T.A.2
-
5
-
-
0344625216
-
Anticonvulsant activity of topiramate and phenytoin in a rat model of ischemia-induced epilepsy
-
Edmonds HL, Jiang YD, Zhang PY, Shank RP. Anticonvulsant activity of topiramate and phenytoin in a rat model of ischemia-induced epilepsy. Life Sci 1996;59:127-31.
-
(1996)
Life Sci
, vol.59
, pp. 127-131
-
-
Edmonds, H.L.1
Jiang, Y.D.2
Zhang, P.Y.3
Shank, R.P.4
-
6
-
-
0002986435
-
Topiramate in childhood epilepsy: Titration, adverse events, and efficacy in multiple seizure types
-
Espe-Lillo J, Ritter FJ, Frost MD, Spiegel RH, Reife R. Topiramate in childhood epilepsy: Titration, adverse events, and efficacy in multiple seizure types. Epilepsia 1995;36:56.
-
(1995)
Epilepsia
, vol.36
, pp. 56
-
-
Espe-Lillo, J.1
Ritter, F.J.2
Frost, M.D.3
Spiegel, R.H.4
Reife, R.5
-
7
-
-
0029922566
-
Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages (and the T.Y.S. Group)
-
Faught E, Wilder BJ, Ramsay RE, Reife RA, Kramer LD, Pledger GW, Karim RM. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages (and the T.Y.S. Group). Neurology 1996;46:1684-90.
-
(1996)
Neurology
, vol.46
, pp. 1684-1690
-
-
Faught, E.1
Wilder, B.J.2
Ramsay, R.E.3
Reife, R.A.4
Kramer, L.D.5
Pledger, G.W.6
Karim, R.M.7
-
8
-
-
0004116672
-
-
London: Cambridge University Press
-
Finney DJ. Probit Analysis. London: Cambridge University Press, 1971.
-
(1971)
Probit Analysis
-
-
Finney, D.J.1
-
9
-
-
0019441262
-
Improved patch clamp technique for high resolution current recording from cells and cell free membrane patches
-
Hamill OP, Marty A, Neher E, Sakmann B, Sigworth F. Improved patch clamp technique for high resolution current recording from cells and cell free membrane patches. Pflugers Arch 1981;391:85-100.
-
(1981)
Pflugers Arch
, vol.391
, pp. 85-100
-
-
Hamill, O.P.1
Marty, A.2
Neher, E.3
Sakmann, B.4
Sigworth, F.5
-
10
-
-
0001607156
-
Preparation of primary cultures of mouse cortical neurons
-
Shahar A, Devillis J, Vernadakis A, Haber B, editors. New York: Alan R. Liss
-
Hertz E, Yu ACH, Hertz L, Juurlink BHJ, Schousboe A. Preparation of primary cultures of mouse cortical neurons. In: Shahar A, Devillis J, Vernadakis A, Haber B, editors. A Dissection and Tissue Culture Manual of the Nervous System. New York: Alan R. Liss, 1990:183-186.
-
(1990)
A Dissection and Tissue Culture Manual of the Nervous System
, pp. 183-186
-
-
Hertz, E.1
Yu, A.C.H.2
Hertz, L.3
Juurlink, B.H.J.4
Schousboe, A.5
-
12
-
-
0028348398
-
Inhibition by topiramate of seizures in spontaneously epileptic rats and DBA/2 mice
-
Nakamura J, Tamura S, Kanda T, Ishii A, Ishihara K, Serikawa T, Yamada J, Sasa M. Inhibition by topiramate of seizures in spontaneously epileptic rats and DBA/2 mice. Eur J Pharmacol 1994;254:83-9.
-
(1994)
Eur J Pharmacol
, vol.254
, pp. 83-89
-
-
Nakamura, J.1
Tamura, S.2
Kanda, T.3
Ishii, A.4
Ishihara, K.5
Serikawa, T.6
Yamada, J.7
Sasa, M.8
-
13
-
-
0025810567
-
Modulation of N-methyl-D-aspartate receptor-mediated increases in cytosolic calcium in cultured rat cerebellar granule cells
-
Parks TN, Artman LD, Alasti N, Nemeth EF. Modulation of N-methyl-D-aspartate receptor-mediated increases in cytosolic calcium in cultured rat cerebellar granule cells. Brain Res 1991;552:13-22.
-
(1991)
Brain Res
, vol.552
, pp. 13-22
-
-
Parks, T.N.1
Artman, L.D.2
Alasti, N.3
Nemeth, E.F.4
-
14
-
-
0029884747
-
Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages (and the T.Y.S. Group)
-
Privitera M, Fincham R, Penry J, Reife R, Kramer L, Pledger G, Karim R. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages (and the T.Y.S. Group). Neurology 1996;46:1678-83.
-
(1996)
Neurology
, vol.46
, pp. 1678-1683
-
-
Privitera, M.1
Fincham, R.2
Penry, J.3
Reife, R.4
Kramer, L.5
Pledger, G.6
Karim, R.7
-
15
-
-
0002836371
-
Topiramate selectively blocks kainate currents in cultured hippocampal neurons
-
Severt L, Coulter DA, Sombati S, DeLorenzo RJ. Topiramate selectively blocks kainate currents in cultured hippocampal neurons. Epilepsia 1995;36:S38.
-
(1995)
Epilepsia
, vol.36
-
-
Severt, L.1
Coulter, D.A.2
Sombati, S.3
DeLorenzo, R.J.4
-
16
-
-
0028221989
-
Topiramate: Preclinical evaluation of a structurally novel anticonvulsant
-
Shank RP, Gardocki JF, Vaught JL, Davis CB, Schupsky JJ, Raffa RB, Dodgson SJ, Nortey SO, Maryanoff BE. Topiramate: Preclinical evaluation of a structurally novel anticonvulsant. Epilepsia 1994;35:450-60.
-
(1994)
Epilepsia
, vol.35
, pp. 450-460
-
-
Shank, R.P.1
Gardocki, J.F.2
Vaught, J.L.3
Davis, C.B.4
Schupsky, J.J.5
Raffa, R.B.6
Dodgson, S.J.7
Nortey, S.O.8
Maryanoff, B.E.9
-
17
-
-
0028138671
-
The dihydropyridine nitrendipine reduces N-methyl-D-aspartate (NMDA)-evoked currents of rodent cortical neurons through a direct interaction with the NMDA receptor-associated ion channel
-
Skeen GA, White HS, Twyman RE. The dihydropyridine nitrendipine reduces N-methyl-D-aspartate (NMDA)-evoked currents of rodent cortical neurons through a direct interaction with the NMDA receptor-associated ion channel. J Pharmacol Exp Ther 1994;271:30-8.
-
(1994)
J Pharmacol Exp Ther
, vol.271
, pp. 30-38
-
-
Skeen, G.A.1
White, H.S.2
Twyman, R.E.3
-
18
-
-
0002544304
-
General Principles: Experimental selection, quantification, and evaluation of anticonvulsants
-
Levy R, Mattson R, Meldrum B, Penry JK, Dreifuss FE, editors. New York: Raven Press
-
Swinyard EA, Woodhead JH, White HS, Franklin MR. General Principles: Experimental selection, quantification, and evaluation of anticonvulsants. In: Levy R, Mattson R, Meldrum B, Penry JK, Dreifuss FE, editors. Antiepileptic Drugs, 3rd ed. New York: Raven Press, 1989:85-102.
-
(1989)
Antiepileptic Drugs, 3rd Ed.
, pp. 85-102
-
-
Swinyard, E.A.1
Woodhead, J.H.2
White, H.S.3
Franklin, M.R.4
-
20
-
-
9444251680
-
Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy
-
Tassinari CA, Michelucci R, Chauvel P, Chodkiewicz J, Shorvon S, Henriksen O, Dam M, Reife R, Pledger G, Karim R. Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy. Epilepsia 1996;37:763-8.
-
(1996)
Epilepsia
, vol.37
, pp. 763-768
-
-
Tassinari, C.A.1
Michelucci, R.2
Chauvel, P.3
Chodkiewicz, J.4
Shorvon, S.5
Henriksen, O.6
Dam, M.7
Reife, R.8
Pledger, G.9
Karim, R.10
-
21
-
-
0024517220
-
Steroid anesthetics and naturally occurring analogs modulate the gamma-aminobutyric acid receptor complex at a site distinct from barbiturates
-
Turner DM, Ransom RW, Yang JS, Olsen RW. Steroid anesthetics and naturally occurring analogs modulate the gamma-aminobutyric acid receptor complex at a site distinct from barbiturates. J Pharm Exp Ther 1989;248:960-6.
-
(1989)
J Pharm Exp Ther
, vol.248
, pp. 960-966
-
-
Turner, D.M.1
Ransom, R.W.2
Yang, J.S.3
Olsen, R.W.4
-
22
-
-
0025032271
-
Development and biological applications of chloride-sensitive fluorescent indicators
-
Verkman AS. Development and biological applications of chloride-sensitive fluorescent indicators. Am J Physiol 1990;259:c375-88.
-
(1990)
Am J Physiol
, vol.259
-
-
Verkman, A.S.1
-
23
-
-
0029899076
-
Topiramate: A potent anticonvulsant in the amygdala-kindled rat
-
Wauquier A, Zhou S. Topiramate: a potent anticonvulsant in the amygdala-kindled rat. Epilepsy Res 1996;24:73-7.
-
(1996)
Epilepsy Res
, vol.24
, pp. 73-77
-
-
Wauquier, A.1
Zhou, S.2
-
24
-
-
0002394897
-
The anticonvulsant topiramate displays a unique ability to potentiate GABA-evoked chloride currents
-
White HS, Brown D, Skeen GA, Wolf HH, Twyman RE. The anticonvulsant topiramate displays a unique ability to potentiate GABA-evoked chloride currents. Epilepsia 1995;36:S39-40.
-
(1995)
Epilepsia
, vol.36
-
-
White, H.S.1
Brown, D.2
Skeen, G.A.3
Wolf, H.H.4
Twyman, R.E.5
-
25
-
-
0026699594
-
Anticonvulsant profile of MDL 27,266: An orally active, broad-spectrurn anticonvulsant agent
-
White HS, Patel S, Meldrum BS. Anticonvulsant profile of MDL 27,266: an orally active, broad-spectrurn anticonvulsant agent. Epilepsy Res 1992;12:217-26.
-
(1992)
Epilepsy Res
, vol.12
, pp. 217-226
-
-
White, H.S.1
Patel, S.2
Meldrum, B.S.3
-
26
-
-
84914561378
-
Design and use of a new electroshock seizure apparatus, and analysis of factors altering seizure threshold and pattern
-
Woodbury LA, Davenport VD. Design and use of a new electroshock seizure apparatus, and analysis of factors altering seizure threshold and pattern. Arch Int Pharmacodyn Ther 1952;92:97-104.
-
(1952)
Arch Int Pharmacodyn Ther
, vol.92
, pp. 97-104
-
-
Woodbury, L.A.1
Davenport, V.D.2
-
27
-
-
26844535090
-
i in ventricular myocytes using a fluorescent indicator
-
i in ventricular myocytes using a fluorescent indicator. Biophys J 1992;61:A445.
-
(1992)
Biophys J
, vol.61
-
-
Xu, P.1
Spitzer, K.W.2
|